Cart
sales@molnova.com
Radezolid
CAS No. 869884-78-6
Radezolid( RX-1741 )
Catalog No. M26804 CAS No. 869884-78-6
Radezolid is a novel oxazolidinone antibiotic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 120 | In Stock |
|
| 5MG | 107 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 339 | In Stock |
|
| 50MG | 514 | In Stock |
|
| 100MG | 733 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRadezolid
-
NoteResearch use only, not for human use.
-
Brief DescriptionRadezolid is a novel oxazolidinone antibiotic agent.
-
DescriptionRadezolid is a novel oxazolidinone antibiotic agent.(In Vitro):Radezolid displays a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis. Radezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) than those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants .
-
In VitroRadezolid MICs are systematically equal to or lower (up to 3 log2 dilutions) than those of linezolid for all linezolid-susceptible strains, with an 8-fold difference for the linezolid-resistant strains. Radezolid shows a greater potency than linezolid, independent of the bacteria tested, when concentrations are expressed on a weight (mg/L) basis. Radezolid shows an improved potency compared to that of linezolid when concentrations are expressed on a weight (mg/L) basis. Radezolid and TR-700 perform well against 3-copy G2447T, G2576T, and G2576T/T2571C mutants.
-
In Vivo——
-
SynonymsRX-1741
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorTNIK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869884-78-6
-
Formula Weight438.463
-
Molecular FormulaC22H23FN6O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 25 mg/mL (57.02 mM)
-
SMILESCC(=O)NC[C@H]1CN(C(=O)O1)c1ccc(c(F)c1)-c1ccc(CNCc2cnn[nH]2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee Y, et al. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells. Oncotarget. 2017 Jun 20;8(25):41091-41101.
molnova catalog
related products
-
Rufloxacin hydrochlo...
Rufloxacin hydrochloride is a fluoroquinolone antibacterial and inhibits topoisomerase. Rufloxacin hydrochloride inhibits B-cell differentiation in human mononuclear cells.
-
NITD-304
NITD-304 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 15 nM against M tuberculosis H37Rv.
-
NITD-564
NITD-564 is a novel, direct inhibitor of the mycobacterial enoyl-reductase InhA with IC50 of 0.59 uM, exhibits MIC50 of 160 nM against Mtb.
